Abivax reported net income of $0.06B for the quarter ended Mar 2026. This income statement covers 12 quarters of results from Dec 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2021 | Dec2022 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.02B | 0.02B | 0.04B | 0.06B | 0.08B | |||||||
| Operating items | ||||||||||||
| Operating Interest Expenses | 0.00B | 0.01B | 0.01B | 15.16B | 0.01B | 0.01B | 0.03B | 53.15B | 0.01B | |||
| Research & DevelopmentR&D | -49.28 | -111.04 | -0.04B | -0.03B | -0.05B | -156.55 | -0.04B | -0.04B | -0.06B | -0.05B | -0.06B | |
| Selling, General & AdministrativeSG&A | -7.65 | -24.10 | -0.01B | -0.01B | -0.01B | -35.16 | -0.01B | -0.01B | -0.03B | -0.03B | -0.01B | |
| Other Operating ExpensesOther Opex | -0.00B | -0.00B | -0.00B | -0.05B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | |||
| Operating ExpensesOpex | -56.93 | -135.14 | -0.05B | -0.04B | -0.06B | -0.05B | -0.05B | -0.05B | -0.10B | -0.08B | -0.07B | |
| Operating IncomeOp. Inc | -0.07B | -0.14B | -0.05B | -0.04B | -0.06B | -0.18B | -0.05B | -0.05B | -0.09B | -0.08B | -0.07B | |
| EBIT | -0.07B | -0.14B | -0.05B | -0.04B | -0.06B | -0.18B | -0.05B | -0.05B | -0.09B | -0.08B | -0.07B | |
| Non-operating items | ||||||||||||
| Non Operating Interest Expenses | -0.00B | -0.01B | -0.01B | -0.00B | -0.01B | -0.01B | -0.11B | -0.01B | -0.01B | |||
| Interest & Investment IncomeInt & Inv Inc | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.02B | 0.01B | 0.01B | |||
| Non Operating IncomeNon Op. Inc. | -21.95 | -3.53 | ||||||||||
| Net income details | ||||||||||||
| EBT | -0.07B | -0.14B | -0.05B | -0.04B | -0.06B | -0.04B | -0.06B | -0.05B | -0.18B | -0.09B | -0.06B | |
| Tax ProvisionsTaxes | -0.01B | -0.00B | ||||||||||
| Profit After TaxPAT | -61.93 | -159.02 | 0.05B | 0.04B | 0.06B | -188.29 | 0.06B | 0.05B | 0.18B | 0.10B | 0.06B | |
| Income from Continuing OperationsIncome (Continuing) | -0.07B | -0.14B | -0.05B | -0.04B | -0.06B | -0.04B | -0.06B | -0.05B | -0.18B | -0.08B | -0.06B | |
| Consolidated Net IncomeConsol Net Inc. | -0.07B | -0.14B | -0.05B | -0.04B | -0.06B | -0.04B | -0.06B | -0.05B | -0.18B | -0.08B | -0.06B | |
| Income towards Parent CompanyParent Net Inc | -0.07B | -0.14B | -0.05B | -0.04B | -0.06B | -0.04B | -0.06B | -0.05B | -0.18B | -0.08B | -0.06B | |
| Net Income towards Common StockholdersNet Income | -0.07B | -0.14B | -0.05B | -0.04B | -0.06B | -0.04B | -0.06B | -0.05B | -0.18B | -0.08B | -0.06B | |
| Additional items | ||||||||||||
| EPS (Basic) | -3.46 | -3.18 | -1.08 | -0.97 | -1.41 | -0.67 | -0.87 | -0.87 | -2.84 | -1.18 | -0.81 | |
| EPS (Diluted) | -3.46 | -3.18 | -1.08 | -0.97 | -1.41 | -0.67 | -0.87 | -0.87 | -2.84 | -1.18 | -0.81 | |
| Shares Outstanding | 0.02B | 0.02B | 0.04B | 0.04B | 0.04B | 0.04B | 0.06B | 0.06B | 0.06B | 0.06B | 0.07B | 0.07B |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.02B | 0.02B | 0.04B | 0.04B | 0.04B | 0.04B | 0.06B | 0.06B | 0.06B | 0.06B | 0.07B | 0.07B |
| EBITDA | -0.07B | -0.14B | -0.05B | -0.04B | -0.06B | -0.18B | -0.05B | -0.05B | -0.09B | -0.08B | -0.07B | |
| Interest ExpensesInt Expense | -0.00B | -0.00B | -0.00B | 15.16B | -0.00B | -0.00B | -0.08B | 53.14B | ||||
| Tax Rate | 7.68 | 0.47 |